![]() |
|
|
Research and Development, Meretek Diagnostics, Inc. and Departments of Pediatrics and Medicine, Baylor College of Medicine, Houston, TX 77030
Breath tests have been used in research laboratories for over 25 y. Originally, the tests were based on the use of 14C, rather than on the nonradioactive isotope, 13C. When 13C became widely available at a reasonable cost, research groups in the United States and Europe developed methodologies to measure 13C abundance in samples of CO2. The tests used a variety of substrates and measured pancreatic function, fat absorption, bacterial overgrowth and P450 mixed-function oxidase. Thus far, the only test to be approved by the Food and Drug Administration is the 13C-urea breath test. This manuscript describes the process by which approval is gained, and indicates the steps necessary for other tests to receive Food and Drug Administration approval.
KEY WORDS: H. pylori carbon-13 13CO2 diagnostic test noninvasive
This article has been cited by other articles:
![]() |
J. W. Fahey, A. Munoz, Y. Matsuzaki, H. Suzuki, P. Talalay, M. Tauchi, S. Zhang, C. Hurt, and A. Yanaka Dietary Amelioration of Helicobacter pylori Infection: Design Criteria for a Clinical Trial Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Matern and M. J. Magera Mass Spectrometry Methods for Metabolic and Health Assessment J. Nutr., May 1, 2001; 131(5): 1615S - 1620. [Abstract] [Full Text] |
||||
![]() |
J. D. Hirschman and J. A. Kresge Synthesis of a Symposium: Innovative Non- or Minimally-Invasive Technologies for Monitoring Health and Nutritional Status in Mothers and Young Children J. Nutr., May 1, 2001; 131(5): 1643S - 1645. [Full Text] |
||||